Robert Battat, MD, is a recognized expert in inflammatory bowel disease (IBD), with a focus on Crohn’s disease and ulcerative colitis. He is an Attending Physician and Scientist at the Centre hospitalier de l’Université de Montréal (CHUM), where he also serves as Director of the CHUM IBD Centre.

Dr. Battat completed his medical degree, internal medicine residency and gastroenterology fellowship at McGill University in Montreal. He then pursued advanced training in IBD through a clinical and research fellowship at the University of California, San Diego, and at Robarts Clinical Trials (Alimentiv). He began his career as a clinician-scientist at Weill Cornell Medicine in New York before becoming director of the CHUM IBD Centre.

A leading voice in IBD research, Dr. Battat has a strong interest in multi-omics in high-risk IBD patients. His extensive scientific publications explore topics such as the impact of bile acids on the microbiome, spatial transcriptomics in post-operative Crohn’s disease, therapeutic drug monitoring and inflammatory profiles in severe ulcerative colitis—using advanced tools like endoscopy and histology to define outcomes. Dr. Battat also leads one of the largest IBD clinical trial programs in Canada to provide patients with more novel treatment options and approaches.

He serves as a peer reviewer for more than 20 scientific journals, sits on multiple editorial boards and contributes to European guidelines for the management of Crohn’s disease and ulcerative colitis. He is also a frequent speaker at national and international medical conferences.

Dr. Battat brings deep expertise in both clinical research and patient care, supporting individuals at every stage of IBD—from the newly diagnosed to those with complex cases involving multiple treatments or surgeries.